These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 32923164)
1. Immune vulnerability of ovarian cancer stem-like cells due to low CD47 expression is protected by surrounding bulk tumor cells. Chang CL; Wu CC; Hsu YT; Hsu YC Oncoimmunology; 2020 Aug; 9(1):1803530. PubMed ID: 32923164 [TBL] [Abstract][Full Text] [Related]
2. The application of HER2 and CD47 CAR-macrophage in ovarian cancer. Chen Y; Zhu X; Liu H; Wang C; Chen Y; Wang H; Fang Y; Wu X; Xu Y; Li C; Lv X; Huang J; Han X; Li R; Hong W; Yu Z; Wei W; Tu J J Transl Med; 2023 Sep; 21(1):654. PubMed ID: 37740183 [TBL] [Abstract][Full Text] [Related]
3. AMPK-mediated CD47 H3K4 methylation promotes phagocytosis evasion of glioma stem cells post-radiotherapy. Sun T; Liu B; Cao Y; Li Y; Cai L; Yang W Cancer Lett; 2024 Feb; 583():216605. PubMed ID: 38218171 [TBL] [Abstract][Full Text] [Related]
4. Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer. Shimizu A; Sawada K; Kobayashi M; Yamamoto M; Yagi T; Kinose Y; Kodama M; Hashimoto K; Kimura T Mol Cancer Res; 2021 Sep; 19(9):1583-1595. PubMed ID: 34016744 [TBL] [Abstract][Full Text] [Related]
5. Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer. Yu L; Ding Y; Wan T; Deng T; Huang H; Liu J Front Immunol; 2021; 12():768115. PubMed ID: 34966389 [TBL] [Abstract][Full Text] [Related]
6. Reprograming immune microenvironment modulates CD47 cancer stem cells in hepatocellular carcinoma. Abd El-Fattah EE; Selim HM Int Immunopharmacol; 2022 Dec; 113(Pt B):109475. PubMed ID: 36435064 [TBL] [Abstract][Full Text] [Related]
7. 4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12. Rodríguez MM; Fiore E; Bayo J; Atorrasagasti C; García M; Onorato A; Domínguez L; Malvicini M; Mazzolini G Mol Ther; 2018 Dec; 26(12):2738-2750. PubMed ID: 30301668 [TBL] [Abstract][Full Text] [Related]
8. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682 [TBL] [Abstract][Full Text] [Related]
9. Eliciting effective tumor immunity against ovarian cancer by cancer stem cell vaccination. Xu H; Zhao F; Wu D; Zhang Y; Bao X; Shi F; Cai Y; Dou J Biomed Pharmacother; 2023 May; 161():114547. PubMed ID: 36933377 [TBL] [Abstract][Full Text] [Related]
10. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer. Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616 [TBL] [Abstract][Full Text] [Related]
11. Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma. Wang JH; Huang ST; Zhang L; Liu ZG; Liang RX; Jiang SW; Jiang YN; Yu XJ; Jiang YC; Li XZ; Zhang PF; Wen ZS; Zheng M Cancer Med; 2019 Mar; 8(3):1315-1325. PubMed ID: 30741466 [TBL] [Abstract][Full Text] [Related]
12. Restoration of miR-340 controls pancreatic cancer cell Xi Q; Zhang J; Yang G; Zhang L; Chen Y; Wang C; Zhang Z; Guo X; Zhao J; Xue Z; Li Y; Zhang Q; Da Y; Liu L; Yao Z; Zhang R J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32503944 [TBL] [Abstract][Full Text] [Related]
13. CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis. Liu R; Wei H; Gao P; Yu H; Wang K; Fu Z; Ju B; Zhao M; Dong S; Li Z; He Y; Huang Y; Yao Z Oncotarget; 2017 Jun; 8(24):39021-39032. PubMed ID: 28380460 [TBL] [Abstract][Full Text] [Related]
14. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer. Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567 [TBL] [Abstract][Full Text] [Related]
15. Cordycepin enhances anti-tumor immunity in colon cancer by inhibiting phagocytosis immune checkpoint CD47 expression. Deng Q; Li X; Fang C; Li X; Zhang J; Xi Q; Li Y; Zhang R Int Immunopharmacol; 2022 Jun; 107():108695. PubMed ID: 35305385 [TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of recipient CD47 inhibits mouse macrophage-mediated immune rejection against human stem cell transplants. Leung CS; Li J; Xu F; Wong ASL; Lui KO FASEB J; 2019 Jan; 33(1):484-493. PubMed ID: 30004796 [TBL] [Abstract][Full Text] [Related]
17. Concurrent Expression of CD47 and CD44 in Colorectal Cancer Promotes Malignancy. Fujiwara-Tani R; Sasaki T; Ohmori H; Luo Y; Goto K; Nishiguchi Y; Mori S; Nakashima C; Mori T; Miyagawa Y; Kawahara I; Fujii K; Kishi S; Tatsumoto N; Kuniyasu H Pathobiology; 2019; 86(4):182-189. PubMed ID: 31132784 [TBL] [Abstract][Full Text] [Related]
18. Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78. Mo L; Bachelder RE; Kennedy M; Chen PH; Chi JT; Berchuck A; Cianciolo G; Pizzo SV Mol Cancer Ther; 2015 Mar; 14(3):747-56. PubMed ID: 25589495 [TBL] [Abstract][Full Text] [Related]
19. CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer. Gu S; Ni T; Wang J; Liu Y; Fan Q; Wang Y; Huang T; Chu Y; Sun X; Wang Y J Immunol Res; 2018; 2018():6156757. PubMed ID: 30525058 [TBL] [Abstract][Full Text] [Related]
20. CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy. Soto-Pantoja DR; Terabe M; Ghosh A; Ridnour LA; DeGraff WG; Wink DA; Berzofsky JA; Roberts DD Cancer Res; 2014 Dec; 74(23):6771-83. PubMed ID: 25297630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]